|View printer-friendly version|
|BrainStorm Cell Therapeutics to Present at the 2017 Disruptive Growth Company Showcase NYC Presented by SeeThruEquity and RHK Capital|
Each company will be provided with a 30-minute time slot to present to an audience of investors and industry professionals and company management will also be available for one-on-one meetings with institutional investors.
Conference registration: complimentary for qualified investors and equity research analysts.
Since its founding in 2011, SeeThruEquity has been committed to its core mission: providing impactful, high quality research on underfollowed smallcap and microcap equities. SeeThruEquity has pioneered an innovative business model for equity research that is not paid for and is unbiased. SeeThruEquity is the host of acclaimed investor conferences that are the ultimate event for publicly traded companies with market capitalizations less than
SeeThruEquity is approved to contribute its research reports and estimates to Thomson One Analytics (First Call), the leading estimates platform on
For more information please visit www.seethruequity.com.
View original content with multimedia:http://www.prnewswire.com/news-releases/brainstorm-cell-therapeutics-to-present-at-the-2017-disruptive-growth-company-showcase-nyc-presented-by-seethruequity-and-rhk-capital-300526532.html